Works by Ahn, Kyu Jeung


Results: 42
    1
    2
    3

    Safety and Efficacy of Modern Insulin Analogues.

    Published in:
    Diabetes & Metabolism Journal, 2013, v. 37, n. 3, p. 181, doi. 10.4093/dmj.2013.37.3.181
    By:
    • Hye Jin Yoo;
    • Keun Yong Park;
    • Kang Seo Park;
    • Kyu Jeung Ahn;
    • Kyung Wan Min;
    • Jeong Hyun Park;
    • Sang Ah Chang;
    • Bong Soo Cha;
    • Dong-Jun Kim;
    • Yong Seong Kim;
    • Tae Keun Oh;
    • Suk Chon;
    • Il Seong Nam-Goong;
    • Mi Jin Kim;
    • Hye-Soon Kim;
    • Young Sik Choi;
    • You Hem Ahn;
    • Sora Leev;
    • Sei Hyun Baik
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    1140-P: Efficacy and Safety of Evogliptin in Patients with Type 2 Diabetes: A Multicenter, Active-Controlled, Randomized Study with Open Label Extension (EVERGREEN Study).

    Published in:
    Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1140-P
    By:
    • LIM, SOO;
    • KIM, GYURI;
    • KWON, HYUK-SANG;
    • PARK, IE BYUNG;
    • AHN, KYU JEUNG;
    • PARK, CHEOL-YOUNG;
    • KWON, SU KYOUNG;
    • KIM, HYE SOON;
    • PARK, SEOK WON;
    • KIM, SIN GON;
    • MOON, MIN KYONG;
    • KIM, EUNSOOK;
    • CHUNG, CHOON H.;
    • WON, KYU CHANG;
    • PARK, KANG SEO;
    • KIM, MIKYUNG;
    • CHUNG, DONG JIN;
    • LEE, CHANG BEOM;
    • KIM, TAE HO;
    • LEE, MOON-KYU
    Publication type:
    Article
    14
    15
    16
    17
    18

    Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.

    Published in:
    Diabetes & Metabolism Journal, 2024, v. 48, n. 4, p. 730, doi. 10.4093/dmj.2023.0077
    By:
    • Jie-Eun Lee;
    • Seung Hee Yu;
    • Sung Rae Kim;
    • Kyu Jeung Ahn;
    • Kee-Ho Song;
    • In-Kyu Lee;
    • Ho-Sang Shon;
    • In Joo Kim;
    • Soo Lim;
    • Doo-Man Kim;
    • Choon Hee Chung;
    • Won-Young Lee;
    • Soon Hee Lee;
    • Dong Joon Kim;
    • Sung-Rae Cho;
    • Chang Hee Jung;
    • Hyun Jeong Jeon;
    • Seung-Hwan Lee;
    • Keun-Young Park;
    • Sang Youl Rhee
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study ( TROICA study)

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 635, doi. 10.1111/dom.12866
    By:
    • Ahn, Chang Ho;
    • Han, Kyung Ah;
    • Yu, Jae Myung;
    • Nam, Joo Young;
    • Ahn, Kyu Jeung;
    • Oh, Tae Keun;
    • Lee, Hyoung Woo;
    • Lee, Dae Ho;
    • Kim, Jaetaek;
    • Chung, Choon Hee;
    • Park, Tae Sun;
    • Kim, Byung Joon;
    • Park, Seok Won;
    • Park, Hyeong Kyu;
    • Lee, Kwang Jae;
    • Kim, Sang‐Wook;
    • Park, Jeong Hyun;
    • Ko, Kwan Pyo;
    • Kim, Chong Hwa;
    • Lee, Hyunjin
    Publication type:
    Article
    33
    34

    Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study.

    Published in:
    Diabetes Therapy, 2021, v. 12, n. 11, p. 2907, doi. 10.1007/s13300-021-01148-1
    By:
    • Kim, Hae Jin;
    • Kim, Young Sik;
    • Lee, Chang Beom;
    • Choi, Moon-Gi;
    • Chang, Hyuk-Jae;
    • Kim, Soo Kyoung;
    • Yu, Jae Myung;
    • Kim, Tae Ho;
    • Lee, Ji Hyun;
    • Ahn, Kyu Jeung;
    • Min, Kyung Wan;
    • Kyung, Eun Jung;
    • Kim, Yeo Kyeong;
    • Lee, Kwan Woo
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42